Compare SGC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGC | RNAC |
|---|---|---|
| Founded | 1920 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.8M | 218.4M |
| IPO Year | 1994 | 2016 |
| Metric | SGC | RNAC |
|---|---|---|
| Price | $13.00 | $6.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $18.00 | ★ $33.67 |
| AVG Volume (30 Days) | 30.0K | ★ 125.5K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $566,184,000.00 | $2,797,000.00 |
| Revenue This Year | $3.02 | N/A |
| Revenue Next Year | $3.83 | N/A |
| P/E Ratio | $92.86 | ★ N/A |
| Revenue Growth | ★ 0.09 | N/A |
| 52 Week Low | $8.30 | $5.60 |
| 52 Week High | $14.59 | $11.00 |
| Indicator | SGC | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 57.95 | 25.62 |
| Support Level | $11.72 | $5.88 |
| Resistance Level | $13.72 | $7.63 |
| Average True Range (ATR) | 0.40 | 0.41 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 91.44 | 0.00 |
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.